|

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease

RECRUITINGSponsored by Association HGE CHU Bordeaux Sud
Actively Recruiting
SponsorAssociation HGE CHU Bordeaux Sud
Started2014-02
Est. completion2030-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02060565

Summary

The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* chronic hepatitis C
* chronic hepatitis B
* alcohol liver disease
* non alcoholic liver disease

Exclusion Criteria:

* ascitis

Conditions2

Chronic Liver DiseaseLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.